ALIBABA-CLOUD
3.11.2022 03:46:36 CET | Business Wire | Press release
Alibaba Cloud, the digital technology and intelligence backbone of Alibaba Group, started its annual Apsara Conference today by announcing the launch of ModelScope, an open-source Model-as-a-Service (MaaS) platform that comes with hundreds of AI models, including large pre-trained models for global developers and researchers. During its flagship conference, the global leading cloud provider also introduced a range of serverless database products and upgraded its integrated data analytics and intelligent computing platform to help customers further achieve business innovation through cloud technologies.
"Cloud computing has given rise to a fundamental revolution in the way computing resources are organized, produced and put to commercial use while shifting the paradigm of software development and speeding up the integration of the cloud and endpoint terminals," Jeff Zhang, President of Alibaba Cloud Intelligence, "As more customers are speeding up with their cloud adoption, we have been upgrading our cloud-based resources, services and tools to become serverless, more intelligent and digitalized in order to lower the barrier for companies to adopt new technology and capture more opportunities in the cloud era."
MaaS to create transparent and inclusive technology community
The ModelScope platform is today launched with over 300 ready-to-deploy AI models developed by Alibaba DAMO Academy ("DAMO"), Alibaba's global research initiative, in the past five years. These models cover various fields from computer vision to natural language processing (NLP) and audio. The platform also includes more than 150 state-of-the-art (SOTA) models, which are recognized globally as the best in their respective fields for achieving the results in a given task.
Also made available on the platform are Alibaba’s proprietary large pre-trained models such as Tongyi, which is capable of turning text into image with five billion parameters, and OFA (One-For-All), a six billion-parameter pre-trained model that excels at cross-modal tasks such as image captioning and visual question answering. Independent developers have also contributed dozens of models to the open-source platform to date.
As an open-source community, ModelScope aims to make developing and running AI models easier and more cost effective. Developers and researchers can simply test the models online for free and get the results of their tests within minutes. They can also develop customized AI application by fine-tuning existing models, and run the models online backed by Alibaba Cloud, or deploy them on other cloud platforms or in a local setting.
The launch underscores DAMO’s ongoing efforts and commitment to promote transparent and inclusive technology by reducing the threshold for building and running AI models, enabling universities and smaller companies to easily use AI for their research and in their business respectively. The community is expected to grow further with more quality models available on the platform from DAMO, partners from research institutes and third-party developers in the near future.
New and upgraded solutions to increase computing efficiency
Staying ahead of the emerging trend of serverless software development, Alibaba Cloud is making its key cloud products serverless to enable customers to concentrate on product deployment and development without worrying about managing servers and infrastructure. Essentially, Alibaba Cloud’s updated products focus on turning computing power into an on-demand capability for users.
Examples of these are the cloud native database PolarDB, the cloud-native data warehouse AnalyticDB (ADB) and ApsaraDB for Relational Database Service (RDS). Leveraging Alibaba Cloud’s serverless technologies, customers can enjoy automatic scaling with extreme elasticity based on actual workloads and a pay-as-you-go billing model to reduce costs. The automatic elastic scaling time on demands can be as little as one second. The use of updated database products can help businesses in the internet industry reduce their costs by 50%, on average, compared to using traditional ones. Currently, Alibaba Cloud has more than 20 serverless key products in total and is adding more product categories to become serverless.
Alibaba Cloud also upgraded its ODPS (Open Data Platform and Services), a self-developed integrated data analytics and intelligent computing platform, to provide companies with diversified data processing and analytics services. The platform can handle both online and offline data simultaneously in one system, providing businesses dealing with complex workloads with analytics for business decision-making with reduced cost and increased efficiency.
ODPS has refreshed global records for big data performance, according to recent results from the Transaction Processing Performance Council (TPC), an industry council that sets the standards for transaction processing and database benchmarking. Evaluated based on a 100 TB data benchmark, the performance of ODPS Maxcompute Cluster attained the top score for the sixth consecutive year. ODPS Hologres Cluster also shown a record-breaking result in the TPC-H 30000GB decision support benchmark test.
To drive workload collaboration between cloud and local hardware, Alibaba Cloud has announced the launch of the Wuying Architecture with a showcase on its applications on the Wuying Cloudbook. The Cloudbook with dedicated Architecture is designed to help users access unlimited computing power on the cloud in a more secure and agile manner while supporting collaboration and flexibility at a workplace.
About Alibaba Cloud
Established in 2009, Alibaba Cloud (www.alibabacloud.com) is the digital technology and intelligence backbone of Alibaba Group. It offers a complete suite of cloud services to customers worldwide, including elastic computing, database, storage, network virtualization services, large-scale computing, security, management and application services, big data analytics, a machine learning platform and IoT services. Alibaba maintained its position as the third leading public cloud IaaS service provider globally since 2018, according to IDC. Alibaba is the world’s third leading and Asia Pacific’s leading IaaS provider by revenue in U.S. dollars since 2018, according to Gartner.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221102006197/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SOLUM and Simbe Expand European Collaboration to Advance Intelligent Store Operations5.3.2026 08:00:00 CET | Press release
SOLUM (KOSPI: 248070) and Simbe announced the expansion of their strategic collaboration to further integrate autonomous store intelligence with SOLUM’s Newton Electronic Shelf Label (ESL) infrastructure across Europe. The collaboration was highlighted at EuroShop, where Simbe’s Store Intelligence™ platform was demonstrated live at the SOLUM booth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260304620371/en/ SOLUM and Simbe announced the expansion of their strategic collaboration to further integrate autonomous store intelligence with SOLUM’s Newton Electronic Shelf Label (ESL) infrastructure across Europe. (Image: SOLUM) Simbe recently introduced Tally 4.0, the next generation of their autonomous shelf-scanning robot, reflecting the company’s continued evolution in retail shelf digitization, incorporating extended runtime, enhanced edge computing, and advanced vision capabilities. Designed to deliver deeper shelf coverag
Mosaic Clinical Technologies Announces FDA Breakthrough Device Designation for Cognita’s Generative AI Model for Radiology5.3.2026 08:00:00 CET | Press release
Breakthrough designation means Cognita™ will engage in prioritized interaction with FDA regarding clearance of device designed to help solve the radiology capacity bottleneck Mosaic Clinical Technologies™, a wholly-owned subsidiary of Radiology Partners, is pleased to announce that Cognita™, its AI business unit developing generative vision-language models (VLMs) for radiology, has received U.S. Food and Drug Administration (FDA) Breakthrough Device Designation for Cognita Chest X-Ray (CXR)™1 across multiple critical indications. Cognita CXR is an industry-first generative vision-language model designed to assist radiologists in the interpretation of chest X-rays and is the first radiology generative AI model, and one of very few radiology AI solutions, to be granted this designation2. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260304633206/en/ Cognita™ operates as the AI business unit of Mosaic Clinical Technologies™, a
Cielo Advances Resilient Remote Connectivity for Its Nationwide Payment Terminal Fleet With Thales5.3.2026 08:00:00 CET | Press release
Cielo, one of Brazil’s leading payment service providers, is piloting remote connectivity management for its point-of-sale (POS) terminals across the country, in partnership with Thales. By deploying Thales’s eSIM connectivity management platform based on the latest GSMA SGP.32 IoT standard, Cielo is accelerating its transition from manual, on-site SIM management to fully remote, secure and resilient connectivity. For Cielo, connectivity is mission critical. When payment terminals lose network access, transactions stop. To strengthen operational resilience and enhance merchant experience, Cielo is modernizing its connectivity architecture across its terminal fleet. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260304089321/en/ Cielo advances resilient remote connectivity for its nationwide payment terminal fleet with Thales. Using Thales’s eSIM technology as part of this strategy, Cielo can remotely switch mobile network op
GAIA and Daiichi Sankyo Europe Enter Exclusive Partnership to Launch Next-Generation Digital Therapeutic for Cardiovascular Care in Europe.5.3.2026 08:00:00 CET | Press release
GAIA, the pioneer in evidence-based digital therapeutics and Daiichi Sankyo Europe, today announced an exclusive strategic partnership to commercialize lipodia upon regulatory approval1. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224658973/en/ Dr. Mario Weiss, Founder & CEO of GAIA AG This digital therapeutic is designed to support adults living with hypercholesterolemia. The comprehensive collaboration brings together GAIA’s long-standing expertise in developing clinically validated non-pharmacological interventions with Daiichi Sankyo’s highly scientific experience in cardiovascular risk management and health. Together, the partners - both members of the German Association of Research-Based Pharmaceutical Companies (vfa) - aim to address a persistent gap in chronic care: leveraging digital technologies to make a difference in patients’ lives by supporting sustainable, long-term behaviour change. Expanding Cardiovasc
Galderma Delivers Record 2025 Results With Net Sales of 5.207 Billion USD, up 17.7% at Constant Currency1, and Core EBITDA2 of 1.211 billion USD, Growing 18.9% at Constant Currency5.3.2026 07:00:00 CET | Press release
Ad hoc announcement pursuant to Art. 53 LR Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its financial results for the full year 2025. Record net sales of 5,207 million USD, surpassing 5 billion USD in a year for the first time and representing 17.7% year-on-year growth on a constant currency1 basis, primarily driven by volume. Broad-based net sales growth, growing double-digits in both International markets and the U.S. Outperforming the market in each product category, with strong net sales growth in Injectable Aesthetics (11.5%), Dermatological Skincare (9.3%) and Therapeutic Dermatology (50.2%), all year-on-year at constant currency. Strong launch momentum across future growth drivers, including Nemluvio® (nemolizumab) delivering 452 million USD in net sales; Relfydess™ (RelabotulinumtoxinA) outperforming expectations in 17 International markets; Sculptra® gaining significant market share in its first year in China; and continued new produ
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
